89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
…, TC Kwee, SG Elias, JA Gietema, SS Bohorquez… - Nature medicine, 2018 - nature.com
Programmed cell death protein-1/ligand-1 (PD-1/PD-L1) blockade is effective in a subset of
patients with several tumor types, but predicting patient benefit using approved diagnostics is …
patients with several tumor types, but predicting patient benefit using approved diagnostics is …
Evaluating the safety and efficacy of crenezumab vs placebo in adults with early Alzheimer disease: two phase 3 randomized placebo-controlled trials
…, B Ostaszewski, SM Sanabria-Bohórquez… - JAMA …, 2022 - jamanetwork.com
Importance Alzheimer disease (AD), a neurodegenerative disease characterized by β-amyloid
plaques and τ tangles in the brain, represents an unmet medical need with no fully …
plaques and τ tangles in the brain, represents an unmet medical need with no fully …
[PDF][PDF] The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake
…, BJ Musser, K Lu, J Yuan, SM Sanabria-Bohórquez… - Cell Metabolism, 2008 - cell.com
Cannabinoid 1 receptor (CB1R) inverse agonists are emerging as a potential obesity therapy.
However, the physiological mechanisms by which these agents modulate human energy …
However, the physiological mechanisms by which these agents modulate human energy …
Safety and efficacy of semorinemab in individuals with prodromal to mild Alzheimer disease: a randomized clinical trial
…, F Brunstein, M Blendstrup, SS Bohorquez… - JAMA …, 2022 - jamanetwork.com
Importance Neurofibrillary tangles composed of aggregated tau protein are one of the
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease severity…
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease severity…
[PDF][PDF] Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults
…, H Bays, P Hollander, SM Sanabria-Bohórquez… - Cell metabolism, 2006 - cell.com
Neuropeptide Y (NPY) is a potent orexigenic neuropeptide, and antagonism of NPY Y1 and
NPY Y5 receptors (NPYxR) is considered a potentially important anti-obesity drug target. We …
NPY Y5 receptors (NPYxR) is considered a potentially important anti-obesity drug target. We …
Occipital activation by pattern recognition in the early blind using auditory substitution for vision
…, E Streel, A Robert, S Sanabria-Bohórquez… - Neuroimage, 2001 - Elsevier
This PET study aimed at investigating the neural structures involved in pattern recognition in
early blind subjects using sensory substitution equipment (SSE). Six early blind and six …
early blind subjects using sensory substitution equipment (SSE). Six early blind and six …
Phase I dose-escalation study of taselisib, an oral PI3K inhibitor, in patients with advanced solid tumors
…, TR Wilson, JA Ware, SM Sanabria Bohorquez… - Cancer discovery, 2017 - AACR
Taselisib is a potent and selective tumor growth inhibitor through PI3K pathway suppression.
Thirty-four patients with locally advanced or metastatic solid tumors were treated (phase I …
Thirty-four patients with locally advanced or metastatic solid tumors were treated (phase I …
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor
…, K Van Laere, S Sanabria-Bohórquez… - Proceedings of the …, 2007 - National Acad Sciences
[ 18 F]MK-9470 is a selective, high-affinity, inverse agonist (human IC 50 , 0.7 nM) for the
cannabinoid CB1 receptor (CB1R) that has been developed for use in human brain imaging. …
cannabinoid CB1 receptor (CB1R) that has been developed for use in human brain imaging. …
[HTML][HTML] Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial
…, RSN Fehrmann, BM Fine, SM Sanabria Bohórquez… - Nature Medicine, 2022 - nature.com
Immune checkpoint inhibitors (ICIs), by reinvigorating CD8 + T cell mediated immunity, have
revolutionized cancer therapy. Yet, the systemic CD8 + T cell distribution, a potential …
revolutionized cancer therapy. Yet, the systemic CD8 + T cell distribution, a potential …
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease
S Sanabria Bohórquez, J Marik, A Ogasawara… - European journal of …, 2019 - Springer
Objective Neurofibrillary tangles (NFTs), consisting of intracellular aggregates of the tau
protein, are a pathological hallmark of Alzheimer’s disease (AD). Here we report the …
protein, are a pathological hallmark of Alzheimer’s disease (AD). Here we report the …